These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7970177)

  • 1. A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3,4-methanopyrrolidine dicarboxylate.
    Bridges RJ; Lovering FE; Koch H; Cotman CW; Chamberlin AR
    Neurosci Lett; 1994 Jun; 174(2):193-7. PubMed ID: 7970177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative autoradiography of Na+-dependent [3H]L-aspartate binding to L-glutamate transporters in rat brain: structure-activity studies using L-trans-pyrrolidine-2,4-dicarboxylate (L-t-PDC) and 2-(carboxycyclopropyl)-glycine (CCG).
    Lieb I; Chebib M; Cooper B; Dias LS; Balcar VJ
    Neurochem Int; 2000 Apr; 36(4-5):319-27. PubMed ID: 10732999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.
    Koch HP; Kavanaugh MP; Esslinger CS; Zerangue N; Humphrey JM; Amara SG; Chamberlin AR; Bridges RJ
    Mol Pharmacol; 1999 Dec; 56(6):1095-104. PubMed ID: 10570036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
    Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
    J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of L-trans-2,4-pyrrolidine dicarboxylate converts the glutamate transport inhibitor from a substrate to a non-substrate inhibitor.
    Esslinger C; Titus J; Koch H; Bridges R; Chamberlin A
    Bioorg Med Chem; 2002 Nov; 10(11):3509-15. PubMed ID: 12213465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in the inhibition of L-glutamate and L-aspartate sodium-dependent high affinity uptake systems in rat CNS synaptosomes by L-trans-pyrrolidine-2,4-dicarboxylate, threo-3-hydroxy-D-aspartate and D-aspartate.
    Mitrovic AD; Johnston GA
    Neurochem Int; 1994 Jun; 24(6):583-8. PubMed ID: 7981641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-trans-pyrrolidine-2,4-dicarboxylate and L-threo-3-hydroxyaspartate on the binding of [3H]L-aspartate, [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), [3H]DL-(E)-2-amino-4-propyl-5-phosphono-3-pentenoate (CGP 39653), [3H]6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and [3H]kainate studied by autoradiography in rat forebrain.
    Balcar VJ; Li Y; Killinger S
    Neurochem Int; 1995 Feb; 26(2):155-64. PubMed ID: 7541266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Na(+)-dependent binding of [3H]L-aspartate in thaw-mounted sections of rat forebrain.
    Li Y; Balcar VJ
    Exp Brain Res; 1994; 97(3):415-22. PubMed ID: 7910564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-trans-2,3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin.
    Willis CL; Humphrey JM; Koch HP; Hart JA; Blakely T; Ralston L; Baker CA; Shim S; Kadri M; Chamberlin AR; Bridges RJ
    Neuropharmacology; 1996 May; 35(5):531-9. PubMed ID: 8887961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters.
    Griffiths R; Dunlop J; Gorman A; Senior J; Grieve A
    Biochem Pharmacol; 1994 Jan; 47(2):267-74. PubMed ID: 7905733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult.
    Koch HP; Chamberlin AR; Bridges RJ
    Mol Pharmacol; 1999 Jun; 55(6):1044-8. PubMed ID: 10347246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and pharmacological analysis of L-[35S]cystine transport into rat brain synaptosomes.
    Flynn J; McBean GJ
    Neurochem Int; 2000 May; 36(6):513-21. PubMed ID: 10762088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate.
    Esslinger CS; Koch HP; Kavanaugh MP; Philips DP; Chamberlin AR; Thompson CM; Bridges RJ
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3101-6. PubMed ID: 9873684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures.
    Blitzblau R; Gupta S; Djali S; Robinson MB; Rosenberg PA
    Eur J Neurosci; 1996 Sep; 8(9):1840-52. PubMed ID: 8921275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices.
    Rae C; Lawrance ML; Dias LS; Provis T; Bubb WA; Balcar VJ
    Brain Res Bull; 2000 Nov; 53(4):373-81. PubMed ID: 11136992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic studies indicate regional variations in the characteristics of L-glutamate transporters in the rat brain.
    Killinger S; Blume GL; Bohart L; Bested A; Dias LS; Cooper B; Allan RD; Balcar VJ
    Neurosci Lett; 1996 Sep; 216(2):101-4. PubMed ID: 8904793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
    Dowd LA; Coyle AJ; Rothstein JD; Pritchett DB; Robinson MB
    Mol Pharmacol; 1996 Mar; 49(3):465-73. PubMed ID: 8643086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
    Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
    Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutamate uptake inhibitor L-trans-2,4-pyrrolidine dicarboxylate is neurotoxic in neonatal rat brain.
    Barks JD; Silverstein FS
    Mol Chem Neuropathol; 1994; 23(2-3):201-15. PubMed ID: 7535531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.